Introduction: Specialist centres have been developed to deliver high-quality Hepatology care. However, there is geographical inequity in accessing these centres in the United Kingdom (UK). We aimed to assess the impact of these centres on decompensated cirrhosis patient outcomes and understand which patients transfer to specialist centres.Methods: A UK multicentred retrospective observational study was performed including emergency admissions for patients with decompensated cirrhosis in November 2019. Admissions were grouped by specialist/non-specialist centre designation, National Health Service region and whether a transfer to a more specialist centre occurred or not. Univariable and multivariable comparisons were made.Results: 1224 admis...
BACKGROUND: Linking persons with hepatitis C virus (HCV) to care and treatment is critical to reduct...
Cirrhosis is morbid and increasingly prevalent, yet the U.S. health care system lacks enough physici...
OBJECTIVES:There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis ...
Introduction: Specialist centres have been developed to deliver high-quality Hepatology care. Howeve...
Admission care bundles have been demonstrated to improve clinical outcomes for patients in several s...
Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited informatio...
Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited informatio...
INTRODUCTION: Close to 30,000 people die of cirrhosis in the USA each year. Previous studies have sh...
BACKGROUND AND AIMS: Patients with decompensated cirrhosis (DC) have significant morbidity and resou...
Objectives: Mortality due to liver disease (of which cirrhosis is the end‐stage) is increasing more ...
Introduction: Hospital admission and mortality rates for patients with cirrhosis in the UK are risi...
Background: Chronic hepatitis C infection (CHC) is a major healthcare problem. Effective anti-viral ...
ObjectivesMortality due to liver disease (of which cirrhosis is the end stage) is increasing more th...
Introduction Liver cirrhosis is increasing worldwide and associated with high mortality. Precise es...
BACKGROUND: Linking persons with hepatitis C virus (HCV) to care and treatment is critical to reduct...
Cirrhosis is morbid and increasingly prevalent, yet the U.S. health care system lacks enough physici...
OBJECTIVES:There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis ...
Introduction: Specialist centres have been developed to deliver high-quality Hepatology care. Howeve...
Admission care bundles have been demonstrated to improve clinical outcomes for patients in several s...
Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited informatio...
Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited informatio...
INTRODUCTION: Close to 30,000 people die of cirrhosis in the USA each year. Previous studies have sh...
BACKGROUND AND AIMS: Patients with decompensated cirrhosis (DC) have significant morbidity and resou...
Objectives: Mortality due to liver disease (of which cirrhosis is the end‐stage) is increasing more ...
Introduction: Hospital admission and mortality rates for patients with cirrhosis in the UK are risi...
Background: Chronic hepatitis C infection (CHC) is a major healthcare problem. Effective anti-viral ...
ObjectivesMortality due to liver disease (of which cirrhosis is the end stage) is increasing more th...
Introduction Liver cirrhosis is increasing worldwide and associated with high mortality. Precise es...
BACKGROUND: Linking persons with hepatitis C virus (HCV) to care and treatment is critical to reduct...
Cirrhosis is morbid and increasingly prevalent, yet the U.S. health care system lacks enough physici...
OBJECTIVES:There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis ...